Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biosimilars
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
fda
2
×
generic drugs
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
alex azar
alirocumab
american patients first
american society of clinical oncology
applied therapeutics
breast cancer
cancer
What
drugs
afternoon
ahead
anticipated
asco
awaited
bio
blueprint
branded
choices
commissioner
consumers
cost
costly
counterweight
cut
details
drug
elevatebio
fda
generic
graft
house
long
lower
meant
medications
plan
pledges
prescription
president
prices
rises
roundup
short
speech
supposed
tenure
trump
unveiled
Language
Current search:
biosimilars
×
photo
×
" raleigh-durham blog main "
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details